tiprankstipranks
Trending News
More News >
HealthLynked (HLYK)
OTHER OTC:HLYK
US Market
Advertisement

HealthLynked (HLYK) AI Stock Analysis

Compare
42 Followers

Top Page

HLYK

HealthLynked

(OTC:HLYK)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
$1.00
▼(-38.65% Downside)
HealthLynked's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues, high net losses, and negative equity. The technical analysis further supports a bearish outlook, with the stock trading below key moving averages and weak momentum indicators. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, indicating potential overvaluation despite the low stock price.

HealthLynked (HLYK) vs. SPDR S&P 500 ETF (SPY)

HealthLynked Business Overview & Revenue Model

Company DescriptionHealthLynked Corp. operates a cloud-based patient information network and record archiving system in the United States. It operates through four divisions: Health Services, Digital HealthCare, Accountable Care Organization/Managed Service Organization (ACO/MSO), and Medical Distribution. The Health Services division provides obstetrical and gynecological medical services to patients; functional medicine focusing on neurodegenerative diseases, such as Alzheimer's, Parkinson's, and multiple sclerosis; and Bridging the Gap Physical Therapy, a physical therapy practice to speed patients' recovery and manage pain without pain medication or surgery. The Digital HealthCare division operates HealthLynked Network, which enables patients and doctors to keep track of medical information via internet in a cloud-based system; and enables patients to enter a detailed online personal medical history, including past surgical history, medications, allergies, and family medical history. This segment also offers online scheduling function for patients to book appointments with providers. The ACO/MSO division operates an ACO and MSO that assists physician practices in providing care to patients via the Medicare Shared Savings Program; and offers contracted consulting services to healthcare providers and other ACOs. The Medical Distribution Division operates as a virtual distributor of discounted medical supplies selling to consumers and medical practice. The company was incorporated in 2014 and is headquartered in Naples, Florida.
How the Company Makes MoneyHealthLynked generates revenue through multiple streams, primarily derived from subscription fees for its health record management services and telehealth platform. The company charges healthcare providers for access to its software solutions, which facilitate patient data management and telemedicine consultations. Additionally, HealthLynked may earn revenue from partnerships with healthcare institutions that utilize its platform to enhance their service offerings. The company also explores opportunities in data analytics and health information exchange, potentially monetizing aggregated health data while ensuring patient privacy. Overall, its diverse revenue model is supported by an increasing demand for digital health solutions and the ongoing transition toward value-based care in the healthcare industry.

HealthLynked Financial Statement Overview

Summary
Income Statement
35
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

HealthLynked Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.63
Price Trends
50DMA
2.05
Negative
100DMA
2.34
Negative
200DMA
3.06
Negative
Market Momentum
MACD
-0.14
Negative
RSI
47.58
Neutral
STOCH
93.06
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLYK, the sentiment is Neutral. The current price of 1.63 is above the 20-day moving average (MA) of 1.54, below the 50-day MA of 2.05, and below the 200-day MA of 3.06, indicating a neutral trend. The MACD of -0.14 indicates Negative momentum. The RSI at 47.58 is Neutral, neither overbought nor oversold. The STOCH value of 93.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HLYK.

HealthLynked Risk Analysis

HealthLynked disclosed 36 risk factors in its most recent earnings report. HealthLynked reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

HealthLynked Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison

HealthLynked Corporate Events

Business Operations and StrategyStock Split
HealthLynked Announces Reverse Stock Split Strategy
Positive
Sep 5, 2025

On September 4, 2025, HealthLynked Corp. announced a reverse stock split as part of its strategy to strengthen its capital structure and improve market positioning. This move aims to increase the per-share price without affecting shareholders’ ownership percentage, thereby enhancing visibility and attracting institutional investors. The company is also advancing its AI healthcare platform and telemedicine services, with ongoing discussions to integrate its technology with major insurance carriers, potentially driving significant recurring revenue and expanding its intellectual property portfolio.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025